Replies to post #200014 on Biotech Values

[DewDiligence]

RVNC—Fully-diluted* shares outstanding was 31.4M at 12/31/15, and it is essentially the same today. (Basic shares outstanding =28.4M.)

*Non-treasury method.

[DewDiligence]

RVNC CC addendum: The full dataset from the BELMONT phase-2 trial in glabellar lines will be presented at AAD this weekend.

[DewDiligence]

RVNC authorizes $75M ATM financing through Cowen:

http://www.sec.gov/Archives/edgar/data/1479290/000119312516495444/d148689d8k.htm

This seems a little premature given RVNC’s liquidity position and cash-burn guidance described in #msg-120921973.

[DewDiligence]

RVNC had $236.6M of cash at 3/31/16 (a reduction of $17.5M relative to 12/31/15):

http://finance.yahoo.com/news/revance-releases-first-quarter-2016-200500014.html

Cash-usage guidance for 2016 remains unchanged at $105-115M.